Latest Period
Q2 2026
Security Snapshot
YD Bio Ltd - Ordinary Shares, par value of US$0.0001 per share (YDES) Institutional Ownership
CUSIP: G98301107
13F Institutional Holders and Ownership History from Q3 2025 to Q2 2026
Institutions Reporting
12
Shares (Excl. Options)
284,252
Price
$2.25
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Ordinary Shares, par value of US$0.0001 per share
- Symbol
- YDES on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 284,252
- Total 13F value
- $639,571
- Portfolio coverage rank
- 0%
- Share change
- +124,732
- Value change
- +$280,649
- Number of holders
- 12
- Shares outstanding
- 70,522,983
- SEC-reported price per share
- $3.90
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- YDES - YD Bio Ltd - Ordinary Shares, par value of US$0.0001 per share is tracked under CUSIP G98301107.
- 12 institutions reported positions in Q2 2026.
- 1 significant owner is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 8 to 12 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $1,228,304 to $639,571.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 12 institutions filings for Q2 2026.
Security key
G98301107
Latest holder period
Q2 2026
13F holders
12
13D/G owners
1
CIK / CUSIP context first
Open Q2 2026 holders
YDES full holder history
YD Bio Ltd SEC filings
YD Bio Ltd company facts
YD Bio Ltd insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP G98301107:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
1
Security
YDES
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Shen Ethan PhD | 77% | -0.05% | $663,552,584 | 54,345,011 | 0% | Ethan Shen | 17 Feb 2026 |
As of 30 Jun 2026, 12 institutional investors reported holding 284,252 shares of YD Bio Ltd - Ordinary Shares, par value of US$0.0001 per share (YDES). This represents 0.4% of the company’s total 70,522,983 outstanding shares.
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
4
Latest
Q2 2026
Rows shown
1-4 of 4